Emerging and Re-emerging Infectious Diseases

  • Thomas LöscherEmail author
  • Luise Prüfer-Krämer
Part of the Statistics for Biology and Health book series (SBH)


Emerging infectious diseases (EIDs) are characterized by a new or an increased occurrence within the last few decades. They include the following categories Emerging diagnosis of infectious diseases: old diseases that are newly classified as infectious diseases because of the discovery of a responsible infectious agent.


Severe Acute Respiratory Syndrome Hemorrhagic Fever With Renal Syndrome Severe Acute Respiratory Syndrome Rift Valley Fever Nipah Virus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurelen W, zur Hausen H (1984) A new type of papillomavirus DNA, its presence in genital cancer and in cell lines derived from genital cancer. EMBO J 3: 1151–1157Google Scholar
  2. Centers for Disease Control (2008) West Nile virus.
  3. Centers for Disease Control (2007) Case information: hantavirus pulmonary syndrome case count and descriptive statistics.
  4. Centers for Disease Control (2006) Norovirus: technical fact sheet.
  5. Centers for Disease Control and Prevention. (1998) World Health Organization: Infection Control for Viral Haemorrhagic Fevers in the African Health Care Setting. Centers for Disease Control and Prevention, AtlantaGoogle Scholar
  6. Chua KB, Bellini WJ, Rota PA et al. (2000) Nipah virus: a recently emergent deadly paramyxovirus. Science 288: 1432–1435CrossRefGoogle Scholar
  7. Correa P, Fox J, Fontham E (1990) Helicobacter and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 66: 2569–2574CrossRefGoogle Scholar
  8. Danielova V et al. (2004) Effects of climate change on the incidence of tick-borne encephalitis in the Czech Republic in the past two decades. Epidemiol Mikrobiol Imunol 53 (4): 174–181Google Scholar
  9. Dondrop AM, Nosten F, Yi P, et al. (2009). Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455–467Google Scholar
  10. Drosten C, Günther S, Preiser W, van der Werf S, et al. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 348: 1967–1976CrossRefGoogle Scholar
  11. Dürst M, Gissmann L, Ikenberg H, zur Hausen H (1983) A papillomavirus DANN from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Nat Acad Sci US 80: 3812–3815CrossRefGoogle Scholar
  12. European Antimicrobial Resistance Surveillance System (2006). Susceptibility results for E. faecium isolates. Available at:
  13. Harit AK, Ichhupujani SG, Gill KS,Shiv Lal, Ganguly NK, Agarwal SP (2006) Indian J Med Res 123: 553–560Google Scholar
  14. Hassler D, Zoller L, Haude M, Hufnagel HD, Sonntag HG (1992) Lyme-Borreliose in einem europäischen Endemiegebiet: Antikörperprävalenz und klinisches Spektrum. Dtsch Med Wochenschr 117: 767–774CrossRefGoogle Scholar
  15. Hofmann J, Meisel H, Klempa B, Vesenbeck SM, Beck R, Michel D, et al. (2008) Hantavirus outbreak, Germany 2007. Emerg Infect Dis 14: 850–852CrossRefGoogle Scholar
  16. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P (2008) Global trends in emerging infectious diseases. Nature 451: 990–993CrossRefGoogle Scholar
  17. Kamar N, Selves J, Mansuy JM, et al. (2008) Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 358: 811–817CrossRefGoogle Scholar
  18. Klevens RM, Jonathan JR. Edwards JR, Richards CL et al. (2007) Estimating Health Care-Associated Infections and Deaths in U.S. Hospitals, 2002. Public Health Report 122: 160–166Google Scholar
  19. Lam SK, Chua KB (2002) Nipah virus encephalitis outbreak in Malaysia. Clin Infect Dis 34 (Suppl 2): S48–51CrossRefGoogle Scholar
  20. Lindgren E, Jaenson TGT (2006) Lyme borreliosis in Europe: influences of climate and climate change, epidemiology, ecology and adaptation measures. WHO Regional Office for Europe, CopenhagenGoogle Scholar
  21. Materna J, Daniel M, Danielova V (2005) Altitudinal distribution limit of the tick Ixodes ricinus shifted considerably towards higher altitudes in central Europe: results of three years monitoring in the Krkonose Mts. (Czech Republic). Cent Eur J Public Health 13 (1): 24–28Google Scholar
  22. Mégraud F (1993) Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am 22: 73–88Google Scholar
  23. Mostashari F, Bunning ML, Kitsutani PT, Singer A (2001) Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 358: 261–264CrossRefGoogle Scholar
  24. Nash D, Mostashari F, Fine A, et al. (2001) Outbreak of West Nile virus infection, New York City area, 1999. N Engl J Med 14: 1858–1859Google Scholar
  25. Organisation Mondiale de la Santé Animale (OIE) (2008).
  26. Parola P, de Lamballerie X, Jourdan J, Rovery C, Vaillant V, Minodier P, Brouqui P, Flahault A, Raoult D, Charrel RN (2006) Novel chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg Infect Dis 12: 1493–1499Google Scholar
  27. Reyes GR, Purdy MA, Kim JP, Luk KC, Young LM, Fry KE, Bradley DW (1990) Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247: 1335CrossRefGoogle Scholar
  28. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M et al. (2007) Infection with Chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370 (9602): 1840–1846CrossRefGoogle Scholar
  29. Robert Koch Institute (2001a). Waldarbeiter-Studie Berlin-Brandenburg 2000 zu zeckenübertragenen und andere Zoonosen. Epidem Bulletin 16: 109–110Google Scholar
  30. Robert Koch Institute (2001b). Risikofaktoren für Lyme-Borreliose: Ergebnisse einer Studie in einem Brandenburger Landkreis. Epidem Bulletin 21: 147–149Google Scholar
  31. Robert Koch Institute (2008a) Norovirus-Winterepidemie 2007/2008 übertrifft die Infektionszahlen der Vorjahre. Epidem Bulletin 6: 44–49Google Scholar
  32. Robert Koch Institute (2008b) Zahl der Hantavirus-Erkrankungen erreichte 2007 in Deutschland einen neuen Höchststand. Epidem Bull 19: 147–152Google Scholar
  33. Rothenbacher D, Bode G, Berg G et al. (1989) Prevalence and determinants of Helicobacter pylori infection in preschool children: a population-based study from Germany. Int J Epidemiol 27: 135–141CrossRefGoogle Scholar
  34. Schmaljohn C, Hjelle B (1997) Hantaviruses: a global disease problem. Emerg Inf Dis 3(2): 95–104CrossRefGoogle Scholar
  35. Shrestha MP, Scott RM, Joshi DM et al. (2007) Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 356: 895CrossRefGoogle Scholar
  36. Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE Jr, Fritsche TR. (1993) Tick-borne diseases in the United States. N Engl J Med 329:936–947Google Scholar
  37. The National Creutzfeld-Jakob Disease Surveillance Unit (NCJDSU) (2008).
  38. Towner JS, Pourrut X, Albariño CG et al. (2007) Marburg virus infection detected in a common African bat. PLoS ONE 2: e764CrossRefGoogle Scholar
  39. Vandenesch F, Naimi T, Enright M, Lina G, Nimmo G, Heffernan H, Liassine N, Bes M, Greenland T, Reverdy M, Etienne J (2003). Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 9: 978–984Google Scholar
  40. Verhoef L, Boxman I, Duizer E, Rutjes SA, Vennema H, Friesema IHM et al. (2008) Multiple exposures during a norovirus outbreak on a river-cruise sailing through Europe, 2006. Eurosurveillance 13(4–6): 1–6Google Scholar
  41. Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366: 1079–1084CrossRefGoogle Scholar
  42. Weiland T, Kuhnl P, Laufs R, Heesemann J (1992) Prevalence of Borrelia burgdorferi antibodies in Hamburg blood donors. Beitr Infusionsther 30: 92–95Google Scholar
  43. Who (2008) Variant Creutzfeld-Jakob disease.
  44. WHO (2004a) Nipah virus outbreaks in Bangladesh. January-April 2004. Wkly Epidemiol Rec 23: 168–171Google Scholar
  45. WHO (2004b) Severe Acute Respiratory Syndrome (SARS). Htttp://
  46. WHO (2005) Revision of the International Health regulations.
  47. Wisplinghoff H, Bischoff T, Tallent SM, et al. (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24 179 cases from a prospective nationwide surveillance study, Clin Infect Dis 39: pp. 309–317CrossRefGoogle Scholar
  48. Wit de M, Widdowson M, Vennema H, de Bruin E, Fernandes T, Koopmans M (2003) Large outbreak of norovirus: The baker who should have known better. J Infect 55(2): 188–193CrossRefGoogle Scholar
  49. Wongsichranalai C, Pickard AL, Wernsdorfer WH, Meshnick SR (2002) Epidemiology of drug-resistant malaria. Lancet Inf Dis 2: 209–218CrossRefGoogle Scholar
  50. Yob JM, Field H, Rashdi AM, Morrissy C, van der Heide B, Rota P, et al. (2001) Nipah virus infection in bats (order Chiroptera) in peninsular Malaysia. Emerg Infect Dis 7: 439–441Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Department of Infectious Diseases and Tropical Medicine (DITM)University of MunichMunichGermany
  2. 2.Travel ClinicBielefeldGermany

Personalised recommendations